+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Long-Term Magnesium Supplementation in Essential Hypertension

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The main objective of this clinical trial was to evaluate the effects of magnesium pidolate (15 mmol/day) on blood pressure at rest and during sympathetic stimulation induced by cold, isometric and tilt test; peripheral blood flow has been evaluated by strain-gauge plethysmography. Fourteen mild to moderate hypertensives (8 males, 6 females, age range 40-60 years) were randomly given magnesium or placebo in a double-blind parallel clinical trial for 6 months. In the actively treated group magnesium urinary excretion increased from 5.3 ± 2 to 7.7 ± 2 mmol/24h, and serum magnesium changed from 0.9 ± 0.1 to 1.0 ± 0.2 mmol/l. On magnesium, BP changed at rest from 156/97 ± 12/4 to 149/90 ± 8/3 mm Hg, during cold pressor test from 169/105 ± 9/6 to 174/105 ± 15/4, during isometric exercise from 170/107 ± 13/9 to 170/105 ± 20/6, and during tilt test from 149/96 ± 11/6 to 153/96 ± 17/7 mm Hg. Similar changes were observed in the placebo group. Peripheral resistances were 14.7 ± 4 and 9.8 ± 2 PRU before and after magnesium, respectively. These data indicate that long-term magnesium pidolate supplementation does not affect blood pressure at rest and during sympathetic stimulation, despite a slight, nonsignificant reduction in forearm peripheral resistance.

          Related collections

          Author and article information

          S. Karger AG
          14 November 2008
          : 81
          : 1
          : 25-33
          aInstitute of Internal Medicine and, Metabolic Diseases and bDepartment of Biochemistry and, Biotechnology, 2nd Medical, School, University of Naples, Naples, Italy
          175772 Cardiology 1992;81:25–33
          © 1992 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          General Cardiology


          Comment on this article